Literature DB >> 17083338

Peripheral neuropathy in type 2 diabetes mellitus in Isfahan, Iran: prevalence and risk factors.

M Janghorbani1, H Rezvanian, A Kachooei, A Ghorbani, A Chitsaz, F Izadi, M Amini.   

Abstract

BACKGROUND: To estimate the prevalence and risk factors of peripheral neuropathy (PN) in people with type 2 diabetes mellitus.
METHODS: A total of 810 patients with type 2 diabetes (289 men and 521 women) from Isfahan Endocrinology and Metabolism Research Centre outpatient clinics, Iran, were examined. Part of examination included an assessment of neurological function including neuropathic symptoms and physical signs and nerve conduction velocity.
RESULTS: The prevalence of PN was 75.1% (95% confidence interval 72.1, 78.0). PN was associated with age, proteinuria, and duration of diabetes, insulin-treatment, and presence of any retinopathy and ischaemic heart disease (IHD). The age-adjusted prevalence rate of PN was 78% higher among patients with IHD, 64% higher among patients with any retinopathy, 66% higher among insulin-treated type 2 diabetes, and it was greater with duration of diabetes. Using a stepwise binary logistic regression model, age, duration of diabetes and proteinuria were significant independent predictors of PN.
CONCLUSION: Peripheral neuropathy is a common complication in this population of Iranian type 2 diabetic patients. It increases with age, duration of diabetes and proteinuria.

Entities:  

Mesh:

Year:  2006        PMID: 17083338     DOI: 10.1111/j.1600-0404.2006.00716.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  21 in total

1.  Expression-based network biology identifies alteration in key regulatory pathways of type 2 diabetes and associated risk/complications.

Authors:  Urmi Sengupta; Sanchaita Ukil; Nevenka Dimitrova; Shipra Agrawal
Journal:  PLoS One       Date:  2009-12-07       Impact factor: 3.240

2.  Risk factors and prevalence of diabetic peripheral neuropathy: A study of type 2 diabetic outpatients in Bangladesh.

Authors:  Kjersti Mørkrid; Liaquat Ali; Akhtar Hussain
Journal:  Int J Diabetes Dev Ctries       Date:  2010-01

3.  Diabetic Peripheral Neuropathy and its Determinants among Patients Attending a Tertiary Health Care Centre in Mangalore, India.

Authors:  Monisha D'Souza; Vaman Kulkarni; Unnikrishnan Bhaskaran; Humam Ahmed; Hegde Naimish; Anjali Prakash; Tabreez S; Bhanu Dahiya; Rekha Thapar; Prasanna Mithra; Nithin Kumar; Ramesh Holla; Darshan Bb; Avinash Kumar
Journal:  J Public Health Res       Date:  2015-07-30

4.  Prevalence of diabetic peripheral neuropathy in Iran: a systematic review and meta-analysis.

Authors:  Sahar Sobhani; Hamid Asayesh; Farshad Sharifi; Shirin Djalalinia; Hamid Reza Baradaran; Seyed Masoud Arzaghi; Morteza Mansourian; Aziz Rezapoor; Hossein Ansari; Mohammad Parvaresh Masoud; Mostafa Qorbani
Journal:  J Diabetes Metab Disord       Date:  2014-10-15

5.  Diabetic peripheral neuropathy in ambulatory patients with type 2 diabetes in a general hospital in a middle income country: a cross-sectional study.

Authors:  María de Los Angeles Lazo; Antonio Bernabé-Ortiz; Miguel E Pinto; Ray Ticse; German Malaga; Katherine Sacksteder; J Jaime Miranda; Robert H Gilman
Journal:  PLoS One       Date:  2014-05-01       Impact factor: 3.240

6.  Diabetes in Iran: Prospective Analysis from First Nationwide Diabetes Report of National Program for Prevention and Control of Diabetes (NPPCD-2016).

Authors:  Alireza Esteghamati; Bagher Larijani; Mohammad Haji Aghajani; Fatemeh Ghaemi; Jamshid Kermanchi; Ali Shahrami; Mohammad Saadat; Ensieh Nasli Esfahani; Morsaleh Ganji; Sina Noshad; Elias Khajeh; Alireza Ghajar; Behnam Heidari; Mohsen Afarideh; Jeffrey I Mechanick; Faramarz Ismail-Beigi
Journal:  Sci Rep       Date:  2017-10-18       Impact factor: 4.379

7.  Comparing of Cox model and parametric models in analysis of effective factors on event time of neuropathy in patients with type 2 diabetes.

Authors:  Sadegh Kargarian-Marvasti; Shahnaz Rimaz; Jamileh Abolghasemi; Iraj Heydari
Journal:  J Res Med Sci       Date:  2017-10-31       Impact factor: 1.852

8.  The cost of diabetes chronic complications among Iranian people with type 2 diabetes mellitus.

Authors:  Amir Farshchi; Alireza Esteghamati; Ali Akbari Sari; Abbas Kebriaeezadeh; Mohammad Abdollahi; Farid Abedin Dorkoosh; Mohamad Ebrahim Khamseh; Rokhsareh Aghili; Abbas Keshtkar; Maryam Ebadi
Journal:  J Diabetes Metab Disord       Date:  2014-03-04

9.  Comparison of the accuracy of monofilament testing at various points of feet in peripheral diabetic neuropathy screening.

Authors:  Shahram Baraz; Kourosh Zarea; Hajie Bibi Shahbazian; Seyed Mahmoud Latifi
Journal:  J Diabetes Metab Disord       Date:  2014-01-28

10.  Cardiovascular Risk Factors Increase the Risks of Diabetic Peripheral Neuropathy in Patients With Type 2 Diabetes Mellitus: The Taiwan Diabetes Study.

Authors:  Chun-Pai Yang; Cheng-Chieh Lin; Chia-Ing Li; Chiu-Shong Liu; Wen-Yuan Lin; Kai-Lin Hwang; Sing-Yu Yang; Hsuan-Ju Chen; Tsai-Chung Li
Journal:  Medicine (Baltimore)       Date:  2015-10       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.